Kolexia
Taille Camille
Pneumologie
Hôpital Bichat-Claude-Bernard
Paris, France
393 Activités
22 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Asthme COVID-19 Maladies pulmonaires Syndrome de Churg-Strauss Granulomatose avec polyangéite Broncho-pneumopathie chronique obstructive Éosinophilie Inflammation Fibrose pulmonaire

Industries

GSK
62 collaboration(s)
Dernière en 2023
AstraZeneca
60 collaboration(s)
Dernière en 2023
Novartis
48 collaboration(s)
Dernière en 2023
Sanofi
41 collaboration(s)
Dernière en 2023

Dernières activités

Bronchial involvement in granulomatosis with polyangiitis.
Revue des maladies respiratoires   08 mars 2024
Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.
ERJ open research   26 février 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
Chest   20 février 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
The journal of allergy and clinical immunology. In practice   14 février 2024
Smoking, Urban Housing and Work-Aggravated Asthma are Associated with Asthma Severity in a Cross-Sectional Observational Study.
Journal of asthma and allergy   01 février 2024
eo-Drive: Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Essai Clinique (CHU Montpellier)   25 janvier 2024
SHORTEN: Impact of Omalizumab Withdrawal After a 3 Year Duration Treatment in Well Controlled Severe Allergic Asthma : a Multicentric Randomized Controlled Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   17 janvier 2024
RAMSES: Research on Severe Asthma
Essai Clinique (Assistance publique – Hôpitaux de Paris)   17 janvier 2024
SECURE: Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
Essai Clinique (GSK)   16 janvier 2024
Written action plans for asthma control: How are they used by pulmonologists in France?.
Revue des maladies respiratoires   15 janvier 2024